GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » Quick Ratio

Pacific Edge (Pacific Edge) Quick Ratio : 6.76 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Pacific Edge's quick ratio for the quarter that ended in Mar. 2024 was 6.76.

Pacific Edge has a quick ratio of 6.76. It generally indicates good short-term financial strength.

The historical rank and industry rank for Pacific Edge's Quick Ratio or its related term are showing as below:

PFGTF' s Quick Ratio Range Over the Past 10 Years
Min: 3.79   Med: 6.47   Max: 18.27
Current: 6.76

During the past 13 years, Pacific Edge's highest Quick Ratio was 18.27. The lowest was 3.79. And the median was 6.47.

PFGTF's Quick Ratio is ranked better than
91.38% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.815 vs PFGTF: 6.76

Pacific Edge Quick Ratio Historical Data

The historical data trend for Pacific Edge's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Quick Ratio Chart

Pacific Edge Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.79 6.18 18.27 10.94 6.76

Pacific Edge Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.27 13.96 10.94 9.78 6.76

Competitive Comparison of Pacific Edge's Quick Ratio

For the Diagnostics & Research subindustry, Pacific Edge's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Edge's Quick Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Edge's Quick Ratio falls into.



Pacific Edge Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Pacific Edge's Quick Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Quick Ratio (A: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(35.204-1.027)/5.059
=6.76

Pacific Edge's Quick Ratio for the quarter that ended in Mar. 2024 is calculated as

Quick Ratio (Q: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(35.204-1.027)/5.059
=6.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Edge  (OTCPK:PFGTF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Pacific Edge Quick Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Edge (Pacific Edge) Business Description

Traded in Other Exchanges
Address
87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

Pacific Edge (Pacific Edge) Headlines

From GuruFocus

Half Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Trading Halt Transcript

By GuruFocus Research 02-14-2024

Full Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Half Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024